Glenmark gets FDA nod for generic Finacea gel

Press enter to search
Close search
Open Menu

Glenmark gets FDA nod for generic Finacea gel

By Sandra Levy - 11/20/2018
Glenmark Pharmaceuticals has received the Food and Drug Administration’s approval for for azelaic acid gel 15%.

The product is the generic version of Leo Pharma’s Finacea gel 15%.

It is indicated for topical treatment of the inflammatory papules and pustules of mild-to-moderate rosacea.

Finacea gel,15% had a market value of about $64.1 million for the period ending September 2018, according to IQVIA.

RELATED TOPICS